UnitedHealthcare to cover Biogen/Ionis’ Spinraza

According to an update by UnitedHealthcare, the company will cover Spinraza (nusinersen) for patients with SMA (spinal muscular atrophy) types 1-3, Bloomberg reported. The drug is produced by Biogen and Ionis Pharmaceuticals. The policy specifies that Spinraza should be prescribed only by physicians with expertise in SMA. Initial authorization will be granted for a maximum of four doses.
(Source Seeking Alpha)